POINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? Yes

Chest - United States
doi 10.1016/j.chest.2019.03.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Should Genetic Information Be Disclosed to Insurers? Yes

BMJ
2007English

Should Red Cell Transfusion Be Individualized? Yes

Intensive Care Medicine
Critical CareIntensive Care Medicine
2015English

POINT: Should Childhood Vaccination Against Measles Be a Mandatory Requirement for Attending School? Yes

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Should Cost Considerations Be Included in Medical Decisions? Yes

Intensive Care Medicine
Critical CareIntensive Care Medicine
2015English

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used to Treat Infections With ESBL-positive Organisms

Journal of Clinical Microbiology
Microbiology
2017English

The Precautionary Principle Should Be Used With Caution — And Should Be Applied to Animal Experimentation and Genetic Manipulation, Not Merely to Protection of the Environment

ATLA Alternatives to Laboratory Animals
GeneticsMolecular BiologyBiochemistryMedical Laboratory TechnologyMedicineToxicology
1999English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Which Test for CAD Should Be Used in Patients With Left Bundle Branch Block?

Cleveland Clinic Journal of Medicine
Medicine
2018English

Unruptured Brain Arteriovenous Malformations Should Be Treated Conservatively: Yes

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy